Biogen Inc (BIIB)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account

Sell

$194.10

Buy

$199.90

arrow-down$-1.11 (-0.56%)

Prices updated at 06 Jun 2026, 00:56 EDT

Prices minimum 15 mins delay

Prices in USD

Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 40% of total revenue in 2025. Biogen also gen ...

NASDAQ

-4.18%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

	$200.66 - $195.14
	$205.97 - $121.05
	-
	28,839.43m
	21.00
	-
	880,438
	1.55
	1,544,344.32
	0.33
	170.60m
	US09062X1037
	9.30
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.